YieldMax MRNA Option Income Strategy ETF

*Potentially incorrect data identified

MRNY
ETF Ticker

+442.20%

+471.95%

NYSE Arca Exchange

Alternative

United States

Enhanced Income

The YieldMax MRNA Option Income Strategy ETF, MRNY_US, is an actively managed strategy providing exposure to United States, Enhanced Income Alternative. It is listed on the NYSE Arca Exchange and has assets under management of $243.0m (as of Oct 30, 2026). The ETF trades in USD and was listed on the exchange on Oct 23, 2023. It has a net expense ratio of 99bps. (All data in USD as of Nov 16, 2026 unless stated.)

The investment strategy governing the actively managed YieldMax MRNA Option Income Strategy ETF seeks current income with capped upside participation in Moderna’s share-price moves. The portfolio gains long MRNA exposure synthetically—typically pairing long call options with short put options sized to approximate 100% notional—then writes short-dated call options or call spreads to harvest premium, accepting a ceiling on upside while remaining exposed to full downside. Options are exchange-traded (including FLEX where useful), cleared, and collateralized with cash and short-term U.S. government instruments. Strike selection and maturities are actively managed to balance premium capture, path-dependency, and participation bands; call spreads may be preferred when the manager targets a defined upside cap. Position limits reflect non-diversified, single-issuer concentration. The overlay is rolled frequently (often weekly), with trims, rolls, or closes executed as option Greeks and market conditions evolve; the fund does not own MRNA shares directly.

ETF Details

Key Facts

Issuer:
YieldMax
AUM:
$243.0m (as of Oct 30, 2026)
Net Expense Ratio:
99 bps
Inception Date:
Oct 23, 2023
Index:
Actively managed strategy
Dividend Frequency:
Monthly

Trading

Ticker:
MRNY
Exchange:
NYSE Arca Exchange
ISIN:
US88634T4691
Trading Currency:
USD
Domicile:
United States

Classification & Risk

Asset Class:
Alternative
Asset Region:
United States
Theme:
Enhanced Income
Economic Development:
Developed Markets
1 Year Volatility:
182.07%
3 Year Volatility:
112.84%
5 Year Volatility:
N/A

Performance

TTM Dividend Yield:
1,285.73% (verify with issuer)
1 Month Performance:
-4.24%
3 Month Performance:
201.39%
6 Month Performance:
265.81%
1 Year Performance:
471.95%
3 Year Performance:
78.04%
5 Year Performance:
N/A
Investment Proposition

YieldMax MRNA Option Income Strategy ETF (MRNY) offers an options-based approach designed to convert the share-price volatility of a single biotechnology company into distributable option premium while maintaining economic exposure to the underlying name. The strategy typically uses derivatives referencing the stock to create a synthetic long stance and systematically sells call options to harvest option income, capping upside participation but seeking steadier cash flows through varied market conditions. Portfolio turnover is inherently high as options are rolled frequently, and outcomes are path-dependent, with distributions linked to realized volatility and option pricing rather than dividends. Returns are primarily driven by the underlying stock’s direction, the shape of the volatility surface, and how quickly markets trend or mean-revert. Use cases include an equity-income satellite for investors comfortable with single-name concentration, a volatility harvesting sleeve within a broader options program, or a tactical overlay to monetize expected range-bound behavior. Suitable profiles include outcome-oriented income seekers who accept capped upside and active traders looking to express a view on volatility. Regimes with sideways markets and elevated volatility are generally favorable; strong, persistent rallies can be challenging. Key risk: single-issuer concentration magnifies idiosyncratic drawdown potential.

ETF Analytics

Fund Discovery

4 Suggestions